Navigation Links
Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
Date:7/31/2009

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) is scheduled to present at the upcoming BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel in New York City on Wednesday, August 5, 2009 at 1:45 p.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until August 31, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules.

The company recently announced positive Phase 2 results for Oral NKTR-118, its proprietary novel peripheral opioid antagonist that combines Nektar's advanced small molecule polymer conjugate technology platform with naloxol, a derivative of the opioid-antagonist drug, naloxone. Nektar's technology has been shown to increase oral bioavailability and inhibit penetration across the blood-brain barrier, an important potential advance for small molecule therapies. The product is being developed to treat opioid-induced constipation (OIC).

NKTR-102, PEGylated irinotecan, is currently in Phase 2 clinical
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
3. Nektar Therapeutics Reports First Quarter 2009 Financial Results
4. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
5. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
6. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
7. Nektar Announces Retirement of Irwin Lerner from Board of Directors
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
9. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
10. Nektar Therapeutics to Webcast R&D Day on November 12th
11. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  Actavis plc (NYSE: ACT ... Court of Appeals for the Second Circuit has issued ... requiring the Company to continue distribution of NAMENDA ® ... http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   "While we are ... we intend to continue our strong efforts to convey ...
(Date:5/22/2015)... May 22, 2015 According to ... (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide Gel, ... Informatics), by Application & by End User - Global ... is expected to reach around $1.98 Billion by 2020 ... 2015 to 2020. Browse 226 ma ...
(Date:5/22/2015)... Charm Sciences, Inc. is pleased ... (USDA), Grain Inspection, Packers and Stockyards Administration (GIPSA) ... Sciences to monitor aflatoxin in grains utilizing Charm’s ... FAST Aflatoxin Quantitative Test (solvent-based). , The Charm ... Water Extraction Technology to extract aflatoxin from the ...
(Date:5/22/2015)... Warren, NJ (PRWEB) May 22, 2015 ... a new white paper that explores the potential of ... industries. The white paper was developed to help life ... they can leverage data to gain critical business insights. ... generated large amounts of data driven by patient profiling, ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences 2New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2
... VRUS ) announced today that it has ... a select group of institutional,investors to sell 1,450,000 ... offering. The investors have agreed to purchase the ... resulting in gross proceeds of,approximately $25.9 million to ...
... Oscar Robertson,s Leading Specialty Chemical ... 24 Disinfectant, SAN DIEGO, Calif., July 15 ... an agreement with Orchem Corporation for,distribution of PURE,s ... brand., (Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO ), Owned ...
... EUR276.3m (First Half: up by ... EUR515.4m) Adjusted Group Results in the Second Quarter Tripled From EUR6.3m to ... EUR17.6m ... DUSSELDORF, Germany, July 15 Gerresheimer AG,again increased its sales and results in the second quarter ...
Cached Biology Technology:Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock 2Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock 3PURE Bioscience Announces Distribution Agreement With Orchem Corporation 2PURE Bioscience Announces Distribution Agreement With Orchem Corporation 3PURE Bioscience Announces Distribution Agreement With Orchem Corporation 4Gerresheimer Further Increases its Sales and Earnings Power 2Gerresheimer Further Increases its Sales and Earnings Power 3Gerresheimer Further Increases its Sales and Earnings Power 4Gerresheimer Further Increases its Sales and Earnings Power 5Gerresheimer Further Increases its Sales and Earnings Power 6
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Recognition Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by ... End User (Government and Utilities, Consumer and Home) - ... Market to grow from $2.77 Billion in 2015 to ... Browse 79 market data Tables and ...
(Date:5/21/2015)... 21, 2015 According to ... Solutions (Hardware, Software, Services), by Applications (Surveillance (Airborne, ... by End-Users (Military & Defense & Commercial) - ... Imaging Market is expected to grow from $7252.0 ... at a Compound Annual Growth Rate (CAGR) of ...
(Date:5/21/2015)... The Sync Project™ , a global ... today announced a collaborative partnership with Berklee,s Institute ... on collaboration on original research, joint course development and ... collaboration, The Sync Project and BerkleeICE are exploring the ... the 2015-2016 academic year.  The course ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... (NYSE:JWa, JWb), a global provider of content and ... and scholarly research; professional development; and education, today ... Library. PDFs read using the ReadCube Web Reader ... and direct access to supplemental content, making it ...
... Colo., USA GSA Bulletin papers published online ... Canada, Mexico, Spain, the UK, and New Zealand. Multiple locations ... Canada, New Zealand, and Guatemala. Papers cover , ... region, USA;, 2. Tectonics, salt, and the fossil forests of ...
... ever wondered why, and how, shoals of fish are comprised of ... Ward, from the University of Sydney in Australia, and Suzanne Currie, ... of different sensory cues to locate shoal-mates, but they are able ... size as themselves. Using these cues, they can form a group ...
Cached Biology News:GSA Bulletin starts 2013 with 13 new papers published online ahead of print 2GSA Bulletin starts 2013 with 13 new papers published online ahead of print 3GSA Bulletin starts 2013 with 13 new papers published online ahead of print 4GSA Bulletin starts 2013 with 13 new papers published online ahead of print 5GSA Bulletin starts 2013 with 13 new papers published online ahead of print 6GSA Bulletin starts 2013 with 13 new papers published online ahead of print 7GSA Bulletin starts 2013 with 13 new papers published online ahead of print 8GSA Bulletin starts 2013 with 13 new papers published online ahead of print 9GSA Bulletin starts 2013 with 13 new papers published online ahead of print 10GSA Bulletin starts 2013 with 13 new papers published online ahead of print 11Nothing fishy about swimming with same-sized mates 2
... Not treated (or medium binding) ... and binds biomolecules through passive interactions,• ... of large molecules, such as antibodies, ... can interact with the surface,• Binding ...
... clear polystyrene formulation , High antibody-binding surface ... , Plates are certified for performance ... , Eight-well strips fit snugly in the ... use even if turned upside down ...
... in vitro diagnostic assays, all EIA/RIA plates ... uniform binding, high optical clarity and low ... part of the Certified Surface Chemistry Programme, ... within QA release specifications. Linkage: This CLS ...
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
Biology Products: